USANA HEALTH SCIENCES INC
USNAUS売上高
$925M
百万USD
営業利益
$37M
百万USD
純利益
$11M
百万USD
ROE
2.0%
最新FY
EPS
$0.58
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $308M | $31M | $1.45 |
| FY2022 | Q1 | $273M | $22M | $1.15 |
| FY2022 | Q2 | $264M | $19M | $1.00 |
| FY2022 | Q3 | $233M | $15M | $0.78 |
| FY2022 | FY | $999M | $69M | $3.59 |
| FY2023 | Q1 | $248M | $18M | $0.95 |
| FY2023 | Q2 | $238M | $17M | $0.89 |
| FY2023 | Q3 | $213M | $11M | $0.59 |
| FY2023 | FY | $855M | $42M | $2.19 |
| FY2024 | Q1 | $228M | $17M | $0.86 |
| FY2024 | Q2 | $213M | $10M | $0.54 |
| FY2024 | Q3 | $200M | $11M | $0.56 |
| FY2025 | Q1 | $250M | $9M | $0.49 |
| FY2025 | Q2 | $236M | $10M | $0.52 |
| FY2025 | Q3 | $214M | $-7M | $-0.36 |
| FY2025 | FY | $925M | $11M | $0.58 |
| FY2026 | Q1 | $250M | $8M | $0.41 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | $1.1B | $999M | $855M | $925M |
| 営業利益 | $139M | $133M | $188M | $146M | $176M | $108M | $66M | $37M |
| 純利益 | $100M | $63M | $126M | $101M | $125M | $69M | $42M | $11M |
| 総資産 | $471M | $519M | $554M | $517M | $641M | $597M | $748M | $743M |
| 純資産 | - | - | - | - | - | - | - | - |
| 自己資本 | $325M | $363M | $391M | $352M | $442M | $434M | $532M | $533M |
| 営業CF | - | $124M | $152M | $127M | $160M | $104M | $61M | $22M |
| EPS | $3.99 | $2.53 | $5.12 | $4.41 | $5.86 | $3.59 | $2.19 | $0.58 |
| BPS | $13.28 | $15.10 | $16.77 | $16.32 | $21.18 | $22.52 | $28.15 | $28.88 |
| ROE | 30.8% | 17.2% | 32.3% | 28.6% | 28.2% | 16.0% | 7.9% | 2.0% |